<DOC>
	<DOCNO>NCT00598559</DOCNO>
	<brief_summary>The study investigate safety efficacy administration repeat dose IV Acetaminophen ( IV APAP ) five day treatment acute pain fever adult patient .</brief_summary>
	<brief_title>Safety Efficacy Intravenous Acetaminophen ( IV APAP ) Adult Inpatients</brief_title>
	<detailed_description>â€¢ To assess safety IV Acetaminophen use five day treatment acute pain fever adult inpatient Secondary Objectives : - To compare efficacy IV Acetaminophen 650 milligram ( mg ) every four ( q4 ) hour vs. 1 gram ( g ) every 6 ( q6 ) hour 5 day treatment - To compare safety IV Acetaminophen 650 mg q4 hour vs. 1 g q6 hour 5 day treatment - To compare safety IV Acetaminophen vs. standard care ( SOC ) treatment 5 day treatment - To compare efficacy IV Acetaminophen vs. standard care treatment 5 day treatment</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Provide write informed consent prior participation Study Be least 18 year age weigh least 41 kilogram ( kg ) Be anticipate Investigator require multiday ( target five day ) use IV treatment either `` nothing mouth '' ( NPO ) status medical condition make oral intake difficult medical condition require IV treatment Be willing undergo 5 day treatment IV acetaminophen treatment pain fever ( define core temperature great equal 38 degree celsius ) . Note Subjects slightly less 15 % chance ( one seven ) assign Control Group receive standard care treatment , IV APAP . Have ability read understand Study procedure ability communicate meaningfully Study Investigator staff If female child bear potential , negative pregnancy test within 48 hour randomization Has significant medical disease , laboratory abnormality condition , Investigator 's judgment , could compromise Subject 's welfare would otherwise contraindicate Study participation Is expect difficulty communicate Study staff complete Study requirement ( include follow visit ) Has know hypersensitivity acetaminophen inactive ingredient ( excipients ) IV acetaminophen contraindication receive acetaminophen Has impair liver function , e.g. , Alanine aminotransferase ( ALT ) great equal 3 time upper limit normal ( ULN ) , bilirubin great equal 3 time ULN , know active hepatic disease ( e.g. , hepatitis ) , evidence clinically significant chronic liver disease condition affect liver ( e.g. , alcoholism define DSMIV , cirrhosis chronic hepatitis ) Has participate interventional clinical Study ( investigational market product ) within 30 day Study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Acute pain</keyword>
	<keyword>Fever</keyword>
	<keyword>IV Acetaminophen</keyword>
	<keyword>Analgesic</keyword>
</DOC>